Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Allogene Therapeutics (ALLO) Times Interest Earned (2024 - 2025)

Allogene Therapeutics (ALLO) has disclosed Times Interest Earned for 2 consecutive years, with -$135.48 as the latest value for Q4 2025.

  • Quarterly Times Interest Earned rose 81.86% to -$135.48 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$194.71 through Dec 2025, up 87.1% year-over-year, with the annual reading at -$194.71 for FY2025, 87.1% up from the prior year.
  • Times Interest Earned hit -$135.48 in Q4 2025 for Allogene Therapeutics, down from -$130.53 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$130.53 in Q3 2025 to a low of -$746.79 in Q4 2024.